These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 34624218)
1. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. Hu H; Piotrowska Z; Hare PJ; Chen H; Mulvey HE; Mayfield A; Noeen S; Kattermann K; Greenberg M; Williams A; Riley AK; Wilson JJ; Mao YQ; Huang RP; Banwait MK; Ho J; Crowther GS; Hariri LP; Heist RS; Kodack DP; Pinello L; Shaw AT; Mino-Kenudson M; Hata AN; Sequist LV; Benes CH; Niederst MJ; Engelman JA Cancer Cell; 2021 Nov; 39(11):1531-1547.e10. PubMed ID: 34624218 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion. Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569 [TBL] [Abstract][Full Text] [Related]
3. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer. Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174 [TBL] [Abstract][Full Text] [Related]
4. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance. Dzobo K; Dandara C OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer. Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859 [TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling. Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515 [TBL] [Abstract][Full Text] [Related]
7. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling. Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063 [TBL] [Abstract][Full Text] [Related]
8. Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients. Li K; Wang R; Liu GW; Peng ZY; Wang JC; Xiao GD; Tang SC; Du N; Zhang J; Zhang J; Ren H; Sun X; Yang YP; Liu DP Sci Rep; 2024 Jul; 14(1):16766. PubMed ID: 39034310 [TBL] [Abstract][Full Text] [Related]
9. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC. Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552 [TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer. Suzuki J; Tsuboi M; Ishii G Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC. Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409 [TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome. Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812 [TBL] [Abstract][Full Text] [Related]
13. CD248-expressing cancer-associated fibroblasts induce non-small cell lung cancer metastasis via Hippo pathway-mediated extracellular matrix stiffness. Wu J; Zhang Q; Yang Z; Xu Y; Liu X; Wang X; Peng J; Xiao J; Wang Y; Shang Z; Wang N; Li L; Zhang R; Zhang W; Zhang J; Zeng Z; Wu J J Cell Mol Med; 2024 Aug; 28(16):e70025. PubMed ID: 39164826 [TBL] [Abstract][Full Text] [Related]
14. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. Yoshida GJ J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182 [TBL] [Abstract][Full Text] [Related]
15. Analysis of gene expression changes associated with human carcinoma-associated fibroblasts in non-small cell lung carcinoma. Wu X; Ruan L; Yang Y; Mei Q Biol Res; 2017 Feb; 50(1):6. PubMed ID: 28231844 [TBL] [Abstract][Full Text] [Related]
16. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer. Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111 [TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cords L; Engler S; Haberecker M; Rüschoff JH; Moch H; de Souza N; Bodenmiller B Cancer Cell; 2024 Mar; 42(3):396-412.e5. PubMed ID: 38242124 [TBL] [Abstract][Full Text] [Related]
18. DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a smoking-associated malignancy index. Su SF; Ho H; Li JH; Wu MF; Wang HC; Yeh HY; Kuo SW; Chen HW; Ho CC; Li KC J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228648 [TBL] [Abstract][Full Text] [Related]
19. CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Zhang T; Zhang P; Li HX Int J Nanomedicine; 2021; 16():561-577. PubMed ID: 33542625 [TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives. Zhang H; Jiang H; Zhu L; Li J; Ma S Cancer Lett; 2021 Aug; 514():38-47. PubMed ID: 34019960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]